its possible soon Phase 2(a) clinical trial update soon. Started phase 2 first week of October.
The initial testing with FSD201 is a 14 day period. That 14 days has now passed. Those will be conclusive soon enough, and reported to share holders.
Beginning of Nov will be the primary endpoint for the Covid-19 study. Congratulations everybody! An already proven to work and proven to be extremely safe drug is so close to being approved to use on COVID-19 patients!!